MLICM
NTNX icon

Metropolitan Life Insurance Company (MetLife)’s Nutanix NTNX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NTNX Stock Details NTNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,012
Closed -$446K – 2536
2021
Q4 		$446K Buy
14,012
+1,100
+9% +$37.7K 0.01% 1519
2021
Q3 		$487K Sell
12,912
-423
-3% -$16K 0.01% 1483
2021
Q2 		$510K Sell
13,335
-376
-3% -$11.7K 0.01% 1508
2021
Q1 		$364K Sell
13,711
-954
-7% -$29K 0.01% 1613
2020
Q4 		$467K Buy
14,665
+490
+3% +$13.3K 0.01% 1398
2020
Q3 		$314K Buy
14,175
+18
+0.1% +$411 0.01% 1516
2020
Q2 		$336K Buy
14,157
+1,976
+16% +$40.9K 0.01% 1478
2020
Q1 		$192K Sell
12,181
-43
-0.4% -$1.21K ﹤0.01% 1610
2019
Q4 		$382K Buy
12,224
+1,914
+19% +$56.5K 0.01% 1495
2019
Q3 		$271K Sell
10,310
-6
-0.1% -$141 ﹤0.01% 1667
2019
Q2 		$268K Sell
10,316
-238
-2% -$8.29K ﹤0.01% 1699
2019
Q1 		$398K Sell
10,554
-221
-2% -$10.1K 0.01% 1442
2018
Q4 		$448K Buy
10,775
+2,555
+31% +$105K 0.01% 1260
2018
Q3 		$351K Sell
8,220
-163
-2% -$8.61K 0.01% 1624
2018
Q2 		$432K Sell
8,383
-25,778
-75% -$1.42M 0.01% 1424
2018
Q1 		$1.68M Buy
34,161
+825
+2% +$32.7K 0.02% 641
2017
Q4 		$1.18M Sell
33,336
-5,062
-13% -$153K 0.02% 817
2017
Q3 		$860K Buy
38,398
+14,067
+58% +$308K 0.01% 1346
2017
Q2 		$490K Buy
24,331
+23,433
+2,609% +$409K ﹤0.01% 1706
2017
Q1 		$17K Hold
898
– – ﹤0.01% 2515
2016
Q4 		$24K Buy
+898
New +$26.8K ﹤0.01% 2621

Other funds holding NTNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NTNX Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nutanix (NTNX) in Q1 2022, closing a stake of 14,012 shares — an estimated $446K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NTNX in Q4 2016 and held it in 21 quarters. The position peaked at $1.68M in Q1 2018. 300 funds tracked by Wall St. Rank hold NTNX as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nutanix position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14,012 Nutanix shares in Q1 2022, an estimated $446K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nutanix in Q4 2016 and held it in 21 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nutanix position peaked at $1.68M in Q1 2018.
  • 300 funds tracked by Wall St. Rank held Nutanix as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.